Ravi Rasendra Mazumdar
Director/Board Member presso BIOCON LIMITED
Patrimonio netto: 17 M $ in data 31/03/2024
Profilo
Ravi Rasendra Mazumdar is currently serving as a Non-Independent Non-Executive Director at Biocon Ltd.
since 2011.
He is also a Director at Glentec International and Biocon Biologics Uk Ltd.
Additionally, he holds the position of Professor at The University of Waterloo and the Indian Institute of Science.
In his former roles, Dr. Mazumdar has worked as a Director at Clinigene International Ltd., Principal at Macrovision Corp., Vice President-Engineering at 98th Street Ventures, Inc., and Professor at The Trustees of Columbia University in The City of New York, McGill University, Purdue University, the University of Essex, and INRS University.
Dr. Mazumdar completed his graduate degree from Imperial College London in 1978.
He obtained his doctorate degree from the University of California, Los Angeles in 1983.
He also holds an undergraduate degree from the Indian Institute of Technology Bombay, which he received in 1977.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOCON LIMITED
0.44% | 23/12/2023 | 5 301 321 ( 0.44% ) | 17 M $ | 31/03/2024 |
| 30/06/2023 | 8 806 ( 0.00% ) | 74 089 $ | 31/03/2024 |
Posizioni attive di Ravi Rasendra Mazumdar
| Società | Posizione | Inizio |
|---|---|---|
| BIOCON LIMITED | Director/Board Member | 01/01/2000 |
| The University of Waterloo | Corporate Officer/Principal | 06/09/2011 |
| Indian Institute of Science | Corporate Officer/Principal | 06/09/2011 |
| Glentec International | Director/Board Member | 06/09/2011 |
Biocon Biologics Uk Ltd.
 Biocon Biologics Uk Ltd. Miscellaneous Commercial ServicesCommercial Services Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers. | Director/Board Member | 19/01/2021 |
Precedenti posizioni note di Ravi Rasendra Mazumdar
| Società | Posizione | Fine |
|---|---|---|
| INRS University | Corporate Officer/Principal | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
| University of Essex | Corporate Officer/Principal | - |
| Purdue University | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Ravi Rasendra Mazumdar
| Imperial College London | Graduate Degree |
| University of California, Los Angeles | Doctorate Degree |
| Indian Institute of Technology Bombay | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOCON LIMITED | Health Technology |
| Aziende private | 5 |
|---|---|
Macrovision Corp.
 Macrovision Corp. Information Technology ServicesTechnology Services Macrovision Corp., provides software and entertainment technology services. It provides services to content owners, software and hardware vendors. It was founded in the year 1983. The company headquaters is located at California. | Technology Services |
98th Street Ventures, Inc.
 98th Street Ventures, Inc. Packaged SoftwareTechnology Services 98th Street Ventures, Inc. develops software for mobile Internet devices. The company was founded by Frank A. O'Donnell, Roger P.Hickey and Paul J. Duggan in 2003 and is headquartered in Evergreen Park, IL. | Technology Services |
| Glentec International | |
Clinigene International Ltd.
 Clinigene International Ltd. Medical/Nursing ServicesHealth Services Clinigene International Ltd. provided clinical research services. The company is headquartered in Bangalore, India. | Health Services |
Biocon Biologics Uk Ltd.
Biocon Biologics Uk Ltd. Miscellaneous Commercial ServicesCommercial Services Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers. | Commercial Services |
- Borsa valori
- Insiders
- Ravi Rasendra Mazumdar
